相关实验视频
Updated: May 20, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.4K
基于区块链技术的多道制药供应链运营战略研究
1School of Business, Qingdao University, Qingdao, 266071, Shandong, People's Republic of China.
Scientific reports
|May 16, 2025
概括
制造商应根据消费者偏好采用在线药品销售的转售或代理销售模式. 区块链技术提高了整个供应链的药品真实性,信任和利能力.
科学领域:
- 供应链管理 供应链管理
- 电子商务是电子商务.
- 区块链技术 区块链技术
背景情况:
- 药品电子商务市场正在增长,制造商正在探索在线销售.
- 区块链技术正在整合,以提高供应链的透明度和真实性.
研究的目的:
- 为了建模一个多道的制药供应链与制造商,零售商和电子商务平台.
- 分析在线销售道和区块链对定价和质量保证的影响.
- 为制造商确定最佳的在线销售策略.
主要方法:
- 制药供应链的差异化游戏模式的开发.
- 分析制造商在线销售道的选择 (再销售与代理销售).
- 模拟使用数值示例和MATLAB来验证模型.
主要成果:
- 消费者的自付成本和在线道偏好决定了制造商的销售模式选择.
- 低消费者自付成本或在线偏好有利于转售模式.
- 高消费者自付成本或在线偏好有利于代理销售模式.
- 区块链的实施增加了制药零售价格和真实性.
- 区块链增强了消费者的信任和感知质量,提高了需求和利能力.
结论:
- 区块链技术对药品定价,真实性和整体供应链利能力产生了积极的影响.
- 由区块链驱动的制造商对质量保证的投资增加,支持长期业务增长.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.5K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.5K
Cellular Membranes and Drug Transport
249
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
249
Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
Drug Delivery: Overview
267
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
267
Nonlinear Pharmacokinetics: Role of Transporters
23
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
23
Drug Distribution: Volume of Distribution
4.2K
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
4.2K

